ライフサイエンスコーパス: baseline value

1 nse (platelet count >/=30 x 10(9)/L and >/=2 baseline value).

2 ints and >50%) or full (LVEF increase to the baseline value).

3 justment for study, treatment, and the above baseline values).

4 1 month of treatment (M1) compared with the baseline value.

5 ce values for each subject to that patient's baseline value.

6 allocated to treatment groups, adjusted for baseline value.

7 hange in BCVA and in CMT with respect to the baseline value.

8 ilation was lowered to less than half of its baseline value.

9 e, GDM decreased to approximately 50% of the baseline value.

10 gery decreased over time by 6% to 28% of the baseline values.

11 cessful resuscitation when compared with the baseline values.

12 nths and 5 years were compared with original baseline values.

13 HbA1c levels were evaluated and compared to baseline values.

14 cantly reduced when compared to pre-ischemia baseline values.

15 cantly larger in most patients compared with baseline values.

16 ere observed following IH dosing compared to baseline values.

17 of the subjects studied before returning to baseline values.

18 een arms in Ki-67 after 4 weeks adjusted for baseline values.

19 ysis of covariance model with adjustment for baseline values.

20 y restored transition probabilities to their baseline values.

21 ding, lower-body fat had not yet returned to baseline values.

22 flow velocity in response to Ach relative to baseline values.

23 eekly until it decreased to less than 20% of baseline values.

24 rovided this was at least a 50% decline from baseline values.

25 ; and ICP (+3.6 +/- 0.7 mm Hg) compared with baseline values.

26 ell subsets), but usually did not recover to baseline values.

27 ine control teeth) were compared to original baseline values.

28 ars, particularly for patients with abnormal baseline values.

29 ht ventricular stem cell expressions to near baseline values.

30 d by 439+/-493 ml (P=0.02), as compared with baseline values.

31 nded area reduced food intake by 42.3% below baseline values.

32 tiation of rilonacept and were compared with baseline values.

33 ult, they hold all other parameters fixed at baseline values.

34 analysis of covariance adjusting for subject baseline values.

35 ds dropped to as low as approximately 10% of baseline values.

36 s were performed until perfusion returned to baseline values.

37 ion was seen after 2 min of US compared with baseline values.

38 and taurine levels declined significantly to baseline values.

39 t different time points after injection with baseline values.

40 not significantly (P > 0.01) different from baseline values.

41 % versus 33+/-5%, respectively; P<0.0001) or baseline values.

42 surement period for either group compared to baseline values.

43 that ranged between 52 and 141% higher than baseline values.

44 after vector infusion and were compared with baseline values.

45 fter the extraction, all markers returned to baseline values.

46 cle reinnervation and reportedly exceed 140% baseline values.

47 tivity at postcoital visits were compared to baseline values.

48 sistance (CVR = MAP/CBF) and MAP relative to baseline values.

49 s were significantly decreased compared with baseline values.

50 post procedure >/=0.5 mg/dL or >/=25% above baseline values.

51 e and not confined to those with the highest baseline values.

52 volume and decreased laterality index versus baseline values.

53 ) at 3 months after surgery, compared to the baseline values.

54 th risk factors for CVD after accounting for baseline values.

55 BO group (prevalence ratio [PR] adjusted for baseline values 0.74, 95% CI 0.62-0.87; p=0.0003).

56 nce decreased by 1.5 miles/day compared with baseline values (-1.5 +/- 1.7 miles/day; P = 0.0005).

57 Thereafter, either CO2 (PaCO2 = baseline value + 10 mm Hg) or N2 (PaO2 = 45-55 mm Hg) wa

58 re not or were imputed conservatively to the baseline value (13.3% vs 5.3%, 95% CI for the estimated

59 cantly increased at follow-up as compared to baseline values (2.0 +/- 0.52 mm vs. 2.25 +/- 0.50 mm, 1

60 htly increased, but was still lower than the baseline value (215 mum, 255 mum, and 299 mum during the

61 alculate hazard ratios (HRs) per 1 SD higher baseline values (4.56 kg/m(2) higher BMI, 12.6 cm higher

62 l4-treated mice (18.3 +/- 6.5) compared with baseline values (5.2 +/- 1.0).

63 7 treated arteries, NEPI levels remained at baseline values (620 to 991 ng/g), </=20% of the nerves

64 observed at 36 months in comparison with the baseline value (77.9 +/- 10.0 ETDRS letters, P = .22).

65 ze or both at 3 months after controlling for baseline values (95% CI, -0.13 to 1.25; P = 0.11).

66 r scar size at 3 months after correcting for baseline values (95% CI, -1.33 to -0.32 mm; P = .001) in

67 xposure to 100% FI,O2 reduced gCBF to 63% of baseline values across all participants.

68 over the subsequent months, returning to the baseline value after 1 year.

69 ime required for the NAP to reach 50% of its baseline value after recovery from hypoxia and the NAP a

70 res and fixed-covariate Cox models with only baseline values after controlling for important clinical

71 2% to -17.6+/-1.6%, P<0.001) and returned to baseline values after delivery (-19.5+/-2%).

72 3-93.1 mL/m(2); P=0.028) but was reversed to baseline values after hTPV implantation (to 65.1 mL/m(2)

73 telet effects with 150 mg, which returned to baseline values after resumption of standard dosing.

74 triphasic viral decay and a viral rebound to baseline values after the cessation of therapy.

75 the two types of matter before returning to baseline values after the completion of repair.

76 hysiological in origin because C returned to baseline values after the rats were killed and corneal a

77 lular frequencies that was dictated by their baseline values, allowing identification of steady-state

78 ar sensitivity was found to shift toward the baseline value, although the return to baseline was not

79 to trophic level), as well as differences in baseline values among the regions in which sharks forage

80 in vitro inotropic effect up to 283% of the baseline value and increased the rates of contraction an

81 The median (interquartile range) baseline value and mean+/-SD annual change of CLurea wer

82 the plasma clearance of iohexol) between the baseline value and the last available value during the f

83 Both the baseline value and the rapidity in change of the value o

84 c mean titers and fold increases relative to baseline values and by comparing changes in the seroconv

85 After adjusting for baseline values and center effect, there was a 21% diffe

86 relation of the number of exacerbations with baseline values and changes in PFTs and CT scores.

87 using mixed-effects models, controlling for baseline values and clustering within practices.

88 0.02) after adjustment for the corresponding baseline values and for several confounding factors asso

89 oup analyses regarding QOL were adjusted for baseline values and gender.

90 morotibial cartilage composition, we studied baseline values and one-year change in superficial and d

91 intention-to-treat basis with adjustment for baseline values and other relevant clinical variables.

92 ens insertion, all variables had returned to baseline values and remained that way for at least 4 hou

93 olute differences relative to the average of baseline values and repeatability analysis were performe

94 The analyses showed that after baseline values and time-dependent confounders were cont

95 (nondisplaceable binding potential) between baseline values and values following methylphenidate inj

96 TE was performed after overnight fasting (baseline values) and 15, 30, 45, 60, 90, and 120 min fol

97 t chains (dFLC) of >20 mg/L, a level >20% of baseline value, and a >50% increase from the value reach

98 Hypothalamic signals were normalized to baseline value, and differences between the pre- and pos

99 g the follow-up period, in percentage of the baseline value, and the incidence of obesity during the

100 ne value, the FVC was 346+/-712 ml above the baseline value, and the residual volume was 333+/-570 ml

101 Arterial pressure did not increase above baseline values, and systemic vascular resistance was un

102 ANCOVA and mixed linear models with sex and baseline value as covariates.

103 a within factor (repeated) of visit, and the baseline value, as well as age and gender, as covariates

104 postoperatively (P </= 0.01) with return to baseline values at 12 months postoperatively (P = 0.57).

105 uximab group, but levels increased to 69% of baseline values at 12 months.

106 ts in both groups progressively returning to baseline values at 30 and 180 days.

107 , were significantly decreased compared with baseline values at 6 months, and the levels became simil

108 NFD approximated baseline values at 6 weeks and did not change any furthe

109 es decreased to 60 +/- 40% and 83 +/- 93% of baseline values at 6-8 months and at 10-14 months, respe

110 anti-dsDNA antibodies fell to 42 +/- 36% of baseline values at 6-8 months and to 37 +/- 33% at 10-14

111 creatinine concentration was unchanged from baseline values at 9 and 24 months.

112 ion in L4 and L5 DRG followed by a return to baseline values at later stages following injury.

113 Compared with baseline values, atorvastatin reduced apoB-100 (-33%), t

114 sulinemic hypoglycemia by 0.36 U (14%) below baseline values (B coefficient, -0.36; 95% confidence in

115 After adjustment for baseline values, back-related function in the yoga group

116 sue is reduced quickly to less than half its baseline value before the creatine phosphate (CrP) pool

117 The difference in baseline values between groups was also examined.

118 res to adjust for the imbalance in covariate baseline values between these two groups.

119 Cardiac output recovered to the baseline value by 5 mins post-RM in oleic acid injury an

120 as reduced if 48-hour urine volumes exceeded baseline values by >/= 10%.

121 therapy, the mean viral loads decreased from baseline values by 0.07 log(10) copies/mL in the placebo

122 ts, cramping, and bleeding returned close to baseline values by 1 year.

123 of 521 nmol/L at 1 d and then a fall to near-baseline values by 7-14 d.

124 is rates decreased by day 3 but recovered to baseline values by day 10.

125 ting CD4(+) T-cell counts, which returned to baseline values by day 30 in 26 of 30 evaluable patients

126 All parameters returned to baseline values by month 12 and remained so at month 36

127 ined at the follow-up were compared with the baseline values by using parametric or nonparametric tes

128 Assigning baseline values carried forward to the 22% of patients w

129 e residual volume was 333+/-570 ml below the baseline value; cerebral lesions were unchanged.

130 ls decreased in the MK-677 group relative to baseline values (change, -0.14 mmol/L [CI, -0.27 to -0.0

131 reased 187- and 4.0-fold, respectively, over baseline values (DAO 0.7 ng/mL, tryptase 76 ng/mL) durin

132 erfusion due to occlusion (from preocclusion baseline values) (%DECREASE) and the maximum increase (f

133 After adjusting for baseline value, demographics, depression, and mental sta

134 d glutamate/GABA concentrations recovered to baseline values during a subsequent muscle contraction.

135 increased at the time of AAD and returned to baseline values during follow-up for these patients with

136 pendent manner, with levels returning toward baseline values during followup.

137 3 mmHg; P < 0.05) and heart rate returned to baseline values during PEMI (83 +/- 3 to 67 +/- 2 beats

138 At HA, OCI returned almost immediately to baseline values during recovery, whereas at SL it remain

139 he return of the discharge creatinine to the baseline value, experienced a significant decrease in th

140 ient increase in the frequency of Tregs from baseline values following acute infection in RM, but no

141 39 +/- 0.004%/h; P < 0.001), but returned to baseline values following BCAA and BCKA ingestion (0.024

142 Elevated GABA+ concentrations returned to baseline values following drug clearance.

143 The mean delta over baseline value for a negative diagnosis was 1.03 +/- 0.8

144 The efficacy population of 47 patients had a baseline value for anti-factor Xa activity of at least 7

145 baseline body mass index, weight change, and baseline value for respective outcomes (P-interaction =

146 The average baseline value for the primary outcome, the attention an

147 increases in the FEV1 at M1 relative to the baseline value for the treated and placebo groups were 1

148 These findings also provide useful baseline values for development of vaccines designed to

149 ly improved prognostic discrimination beyond baseline values for fatal outcomes only.

150 Lower baseline values for FEV1, smaller bronchodilator respons

151 P (g=0.34) and differences between groups in baseline values for LV end-diastolic volume index and LV

152 to compare QoL at 3, 6, 18, and 36 months to baseline values for patients categorized into 2 groups:

153 d sex, ethnicity, age, disease duration, and baseline values for rheumatoid factor and the tender and

154 No changes were found with respect to baseline values for SNIUAA and control groups.

155 Baseline values for the chemokine CXCL16 was an independ

156 ation of symptoms before admission and lower baseline values for viral load and for serum creatinine

157 neumococcal meningitis were assessed against baseline values from 1998-1999.

158 NP was measured in 2,080 patients; 1,292 had baseline values >1,000 pg/ml and were reassessed at 1 an

159 equal or greater than 3 logs compared with a baseline value have a significantly better progression-f

160 Baseline values have also been shown to be prognostic in

161 ter treatment, there was no improvement from baseline values (i.e., reduction) in wall motion score (

162 in the temperature greater than the diurnal baseline values identified the onset of the systemic res

163 se in serum creatinine level from the stable baseline value in <6 months or an increase of >/= 0.3 mg

164 on rate (GFR) to </=60 mL/min or to half the baseline value in subjects who entered with GFR <120 mL/

165 the occlusion and remains within 30% of its baseline value in vessels as far as 10 branch points dow

166 de 3: n = 1) but creatinine/eGFR returned to baseline values in all patients.

167 , and c-myo-miR-206 were not reverted to the baseline values in crewmember A.

168 Despite near-normal mean baseline values in FEV1, patients receiving ivacaftor ha

169 aminotransferase at week 12 compared to the baseline values in LAL-CL01 were 46 +/- 21 U/L (-52%) an

170 as variability over time) over and above the baseline values in logistic regression models.

171 -up, HOMA2-IR and BMI levels returned toward baseline values in patients who did not respond or relap

172 OVB, there were significant reductions from baseline values in proximal (P=.002), mid (P=.0003), and

173 Whereas the number of NK cells returned to baseline values in the blood, the GI tissues remained de

174 ported significantly less pain compared with baseline values in the final week of treatment than did

175 and should provide explicit estimates of the baseline values in the original data space for optimal d

176 tions performed in the same rats and between baseline values in treated and control rats, respectivel

177 vely stable (composite end point relative to baseline values) in >/=85% of patients as well as indivi

178 s for 2030 required major decreases (<33% of baseline values) in consumption of beef, pork, cheese, s

179 statistically significant improvements from baseline values, including wKT in the EMD group, which a

180 whose galectin-3 stayed within +/-15% of the baseline value, independent of age, sex, diabetes mellit

181 nergic stimulation than those who had better baseline values, indicating that a cholinergic deficit c

182 ractitioner could input a patient's relevant baseline values into a handheld computer programmed with

183 decrease in cell stiffness back towards the baseline value is consistent with a replacement of the o

184 The changing baseline values lead to potential compliance challenges

185 mean diffusivity (MD) was unchanged despite baseline values lower than controls (p < 0.05), and frac

186 As baseline values may have impact on the treatment respons

187 10 mg/kg/d deferasirox groups, respectively (baseline values [means +/- SD], 13.11 +/- 7.29 and 14.56

188 ed, NADH fluorescence and Psi(m) returned to baseline values much faster than mitochondrial [Ca2+].

189 Improvement in renal function, compared with baseline values, occurred in 27% of recipients 1 month a

190 he urine of the 19 patients increased from a baseline value of 19% to 63% (P=0.02).

191 acerbations, CAT scores rose from an average baseline value of 19.4 +/- 6.8 to 24.1 +/- 7.3 (P < 0.00

192 ximum amplitude in TEG) was decreased from a baseline value of 72.2 +/- 1.4 mm to 56.2 +/- 3.1 mm (P

193 ty (angle alpha in TEG) was decreased from a baseline value of 73.3 +/- 1.1 degree to 63.0 +/- 2.4 de

194 with the concentration of attractant from a baseline value of 8-42 microm(2)/s at a concentration of

195 ompared with placebo, was 59%, from a median baseline value of 92 mg per deciliter (2.4 mmol per lite

196 tivity in non-small-cell lung cancer and the baseline value of CD16, CD56, CD69 triple-positive activ

197 ment for age, sex, smoking, BMI, season, and baseline value of each metabolic outcome variable.

198 A baseline value of LVS < 0.84 or IVS >/= 18.8 degrees pre

199 e assessed with a mixed model with terms for baseline value of the response variable, age, sex, regio

200 n, or toxic effects, stratified according to baseline value of TrPAL (</= or > the upper limit of nor

201 , received > or =30 days of therapy, and had baseline values of absolute CD4, %CD4, and HIV-1 RNA.

202 Baseline values of all four variables were predictive of

203 ith progression to cirrhosis included higher baseline values of and greater increases in hepatic coll

204 was trained to predict individual risk from baseline values of cholinesterase, bilirubin, type of pr

205 p, presence of type 2 diabetes mellitus, and baseline values of each dependent variable.

206 luding 4 children (</=3 years old) to define baseline values of early life and 12 adults (>/=18 years

207 Baseline values of estradiol and estrone sulfate were si

208 Although baseline values of FLC are prognostic in newly diagnosed

209 Higher baseline values of HbA1c were associated in a graded fas

210 We aimed to 1) determine baseline values of iron and inflammatory markers in chil

211 n allocation among participants with greater baseline values of N-BNP.

212 top third with those in the bottom third of baseline values of natriuretic peptides, the combined ri

213 ed after periodontal treatment compared with baseline values of periodontitis patients (P < .001).

214 trial database to develop two models, using baseline values of routinely available laboratory tests

215 Baseline values of serum glucagon were not different bet

216 After adjustment for baseline values of several established risk factors, the

217 Replication analysis showed that baseline values of surfactant protein D (46.6 ng/mL vs 3

218 anges from baseline and the relation between baseline values of these variables to sustained virologi

219 d butter and increased consumption (>150% of baseline values) of legumes, fish and shellfish, peanuts

220 ved replicate grades within two steps of the baseline value on the AREDS severity scale for temporal

221 Path analyses examined the impact of baseline values on 1-year values for each of the 4 varia

222 A for overall treatment effect, adjusted for baseline values); only the higher dose of gabapentin was

223 increase in serum creatinine >1.5 times the baseline value or a new requirement for renal replacemen

224 re no associations between systemic factors (baseline values or change from baseline) and mean change

225 hese null or favourable associations between baseline values or changes in aBMD, bone microstructure

226 agent exposure was screened and revealed no baseline values or potential interferences.

227 ered (P > 0.80) when compared with untreated baseline values or vehicle-treated control eyes.

228 uding decaying oscillations returning to the baseline value over 35-100 s, oscillations superimposed

229 s are compared relative to their diesel-only baseline values over transient and steady state testing.

230 volume at 12 months was 53.2+/-26.6% of the baseline value (P<0.001) and at 24 months was 85.9+/-28.

231 4 weeks, that was more than eight times the baseline value (P<0.001), without affecting CD4+ convent

232 ased to a median of more than five times the baseline value (P<0.001).

233 nths, CFI was 0.14+/-0.07 or 63+/-27% of the baseline value (P<0.001).

234 01) and at 24 months was 85.9+/-28.5% of the baseline value (P=0.005).

235 and nrCBF significantly increased for higher baseline values (P < .01).

236 nce signal of arthritic joints compared with baseline values (P < 0.05).

237 ll groups after training compared with their baseline values (P < 0.05).

238 BOP and PD decrease and CAL gain compared to baseline values (P <0.05).

239 one and RYGB plus omentectomy, compared with baseline values (P<.001).

240 y bypass, MMP activity increased by 20% from baseline values (P<0.05), and then rapidly fell with car

241 e to treatment was significantly modified by baseline values (P-interaction = 0.02), with the increas

242 Compared with baseline values, patients treated with atorvastatin had

243 After analysis was controlled for baseline values, patients who underwent autologous recon

244 on RIF counts were significantly higher than baseline values, peaking at 5 min (average, 3.93 +/- 2.5

245 tenuated in both scenarios compared with the baseline values.Potential industry-wide reformulation of

246 riance model that adjusted for treatment and baseline values (principal efficacy prespecified at 8 mo

247 month to become maximal, but returned toward baseline values rapidly once rats resumed ad libitum die

248 Compared with the baseline values, RD, RW, CAL, and root surface area decr

249 the respective rates of change, with higher baseline values relating to faster reductions.

250 5% (p < 0.01) and 45 +/- 6% (p < 0.05) from baseline values, respectively, achieving near normal val

251 mean +/- SD of 64 +/- 37% and 38 +/- 33% of baseline values, respectively, by 6-8 months post-BCDT.

252 After adjustment for baseline values, serum hepcidin levels were higher at Da

253 alyses for complete-cases and adjustment for baseline values showed similar results.

254 In an intent-to-treat analysis with baseline value substitution, mean weight loss was 7.4 kg

255 7.9%; 95% CI, 81.2%-94.6%) who established a baseline value that could be used as a reference for fut

256 ontinued, the FEV1 was 62+/-411 ml above the baseline value, the FVC was 346+/-712 ml above the basel

257 Compared with baseline values, the fractional synthesis rate of erythr

258 Compared with baseline values, the mean sub-basal nerve density decrea

259 As compared with baseline values, the normalized total atheroma volume sh

260 hese parameters subsequently returned toward baseline values, the observed differences between the tr

261 Compared with baselines values, the mean subbasal nerve density (P < 0

262 t 8 weeks (P<0.001 for both comparisons with baseline values), then declined when the patients were n

263 choalveolar lavage and became similar to the baseline value thereafter.

264 le to achieve performances very close to the baseline value, thus providing good support for the use

265 n increase in serum creatinine >25% from the baseline value to 30 day was significantly lower in pati

266 xpiratory volume in 1 second (FEV1) from the baseline value to the average of the week 4 and week 8 m

267 in these HIV-1-infected children moved from baseline values to about halfway to two-thirds of the wa

268 Comparing pediatric liver stiffness to adult baseline values to detect pediatric liver mechanical abn

269 analysis of covariance while controlling for baseline values to examine intervention effects and cond

270 epeated measures was used, including patient baseline value, treatment, visit, and treatment-by-visit

271 14.1 +/- 5.1 to 15.9 +/- 6.8 (P<0.05), with baseline values trending higher among individuals who re

272 g water was significantly different from the baseline value until 2 hours after bronchoalveolar lavag

273 After 8 wk, with baseline values used as a covariate, no differences were

274 n of values obtained at weeks 4 and 8 to the baseline value was 0.53 in the sacubitril-valsartan grou

275 The recovery to baseline values was almost complete for NGG whereas GG s

276 increase in B-6 vitamer concentrations over baseline values was observed after 28 d of treatment wit

277 Baseline values were available in 296 patients, and of t

278 Baseline values were calculated per tissue combining all

279 aired analyses of the differences from these baseline values were conducted by finding the mean diffe

280 w-up variables that showed collinearity with baseline values were not retained in the final model.

281 However baseline values were re-established with 20 minutes.

282 After the stressor, sAA (p=0.026) baseline values were reached considerably faster in the

283 Tracheal baseline values were significantly higher in children wi

284 Daily peak serum creatinine (adjusted for baseline) values were also associated with delirium (OR,

285 R scores (adjusted for clinic site, sex, and baseline values) were not different between groups.

286 ed reduction in physical activity returns to baseline values when weight loss is maintained.

287 and PML edge markers from the MA plane from baseline values while leaflet length was obtained by sum

288 xposed group collectively approached 100% of baseline values, while that of the control group was in

289 individuals and demonstrate that individual baseline values will be essential for predicting disease

290 retinal sensitivity tests for comparison of baseline values with 6 months after surgery.

291 values >14, or 2 increases of > or = 5 from baseline values with at least one value > or = 12.

292 atients were matched for age, race, sex, and baseline values with patients who had never received tre

293 fore rituximab therapy, and a reduction from baseline values with rituximab therapy was observed for

294 5%) lean mass (both P < 0.0001 compared with baseline values), with no differences between 25% and 15

295 ) visceral fat (all P < 0.0001 compared with baseline values), with no differences between the diets

296 of > or = 20 mmHg in SBP compared with their baseline value, with a mean change of 20.6 mmHg (P < .00

297 serum creatinine concentration >25% from the baseline value within a 3-day period.

298 Platelet counts generally returned to baseline values within 2 weeks after the end of treatmen

299 65 g/kg at 24 h (P < 0.01) below established baseline values within 24 h without significant changes

300 ction test parameters (PFTs) return to their baseline values within a few weeks.